Objectif The effects of glycosylation of proteins are gaining more and more importance, e.g. requirements. Numerous production techniques of recombinant proteins as drugs are developed at the moment. The quality for the pharmaceutical effect of those drugs is often dependent on the glycosylation status. Therefore a constantglycosylation is most crucial and needs to be monitored. Healthcare Technologies has developed a system and reliable method of glycosylation fingerprinting. Phytowelt is working on the production of recombinant proteins in plants and normal profiling by coda micro arrays. To access the utility of this production system both companies aim to evaluate the compatibility of their diagnostic systems to develop a safe and cost efficient production method combined with a method to monitor product quality and reliability in a cost efficient way. Champ scientifique medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsnatural sciencesbiological sciencesbiochemistrybiomoleculesproteins Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Thème(s) 1.1.1.-3. - Key action The "Cell factory" Appel à propositions Data not available Régime de financement EAW - Exploratory awards Coordinateur PHYTOWELT GMBH Contribution de l’UE Aucune donnée Adresse Kölsumer Weg 33 41334 NETTETAL Allemagne Voir sur la carte Coût total Aucune donnée Participants (1) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire HEALTHCARE TECHNOLOGIES LTD Israël Contribution de l’UE Aucune donnée Adresse 3, habosem St., Kiryat Minrav, 77601 ASHDOD Voir sur la carte Coût total Aucune donnée